KwikPen® for single-patient use available from Lilly at $449 across all doses through the Lilly Employer Connect platform, with reduced cost-share ...

At 36 weeks in the TOGETHER-PsO study, concomitant Taltz and Zepbound met primary endpoint of superiority vs. Taltz monotherapy in achieving complete skin clearance (PASI 100) and ≥10% weight loss In ...

Alternatives to Ozempic for Weight Loss This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Ozempic is an ...

In the shadowed caves of ancient India, Siddhartha Gautama sat under a bodhi tree, wrestling with the hydra-headed beast of ...

Please provide your email address to receive an email when new articles are posted on . The Zepbound KwikPen allows patients to receive four doses of the drug in a single pen device. According to Eli ...

Brianna LaPaglia issues a candid message about Ozempic after saying she knows several people who use the drug and don't need it ...

Eli Lilly plans to ​invest $3 billion over ‌the next decade to expand supply ​chain capacity in ​China and build production ⁠capacity for ​type-2 diabetes and obesity ​treatment orforglipron, the ...

By Stine Jacobsen and Maggie Fick COPENHAGEN, Feb 23 (Reuters) - Novo Nordisk's next-generation obesity drug CagriSema underperformed Eli Lilly's Zepbound in a head-to-head trial, the Danish drugmaker ...

TrumpRx is primarily for people who pay for their prescriptions out-of-pocket. There may be cheaper generic options at direct ...

Lilly launches four-dose Zepbound KwikPen in the US. Self-pay starter price begins at $299 per month. Move aims to improve retention in crowded GLP-1 market. Millions of people on GLP-1 weight-loss ...

The results of this obesity medication are literally eye-popping. A new review of adverse effects reports to the FDA between the years 2017 and 2024 reveals that Ozempic and Wegovy have both been ...

The Tennessee Poison Center is seeing a sharp increase in calls related to tirzepatide and semaglutide exposure over the last ...